SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Bruna C. Bertol, Simone Moreira, Raquel F. L. Garcia, Leslie E. Ferreira, Guilherme Debortoli, Mauro de Souza Leite Pinho, Marcia Amendola-Pires, Alessandra M. de Almeida Maciel, Carlos E. Brandço-Mello, Paulo H. C. de França, IL28B gene polymorphisms in mono- and HIV-coinfected chronic hepatitis C patients, Frontiers in Microbiology, 2015, 6,

    CrossRef

  2. 2
    Thomas Berg, Pietro Andreone, Stanislas Pol, Stuart Roberts, Zobair Younossi, Moises Diago, Eric J. Lawitz, Roberto Focaccia, Graham R. Foster, Andrzej Horban, Isabelle Lonjon-Domanec, Ralph DeMasi, Gaston Picchio, Donghan Luo, Sandra De Meyer, Stefan Zeuzem, Low-density lipoprotein and other predictors of response with telaprevir-based therapy in treatment-experienced HCV genotype 1 patients: REALIZE study, Liver International, 2015, 35, 2
  3. 3
    Robert G. Gentles, Min Ding, John A. Bender, Carl P. Bergstrom, Katharine Grant-Young, Piyasena Hewawasam, Thomas Hudyma, Scott Martin, Andrew Nickel, Alicia Regueiro-Ren, Yong Tu, Zhong Yang, Kap-Sun Yeung, Xiaofan Zheng, Sam Chao, Jung-Hui Sun, Brett R. Beno, Daniel M. Camac, Chong-Hwan Chang, Mian Gao, Paul E. Morin, Steven Sheriff, Jeff Tredup, John Wan, Mark R. Witmer, Dianlin Xie, Umesh Hanumegowda, Jay Knipe, Kathy Mosure, Kenneth S. Santone, Dawn D. Parker, Xiaoliang Zhuo, Julie Lemm, Mengping Liu, Lenore Pelosi, Karen Rigat, Stacey Voss, Yi Wang, Ying-Kai Wang, Richard J. Colonno, Min Gao, Susan B. Roberts, Qi Gao, Alicia Ng, Nicholas A Meanwell, John F. Kadow, Discovery and Preclinical Characterization of the Cyclopropylindolobenzazepine BMS-791325, A Potent Allosteric Inhibitor of the Hepatitis C Virus NS5B Polymerase, Journal of Medicinal Chemistry, 2014, 57, 5, 1855

    CrossRef

  4. 4
    Nezam Afdhal, K. Rajender Reddy, David R. Nelson, Eric Lawitz, Stuart C. Gordon, Eugene Schiff, Ronald Nahass, Reem Ghalib, Norman Gitlin, Robert Herring, Jacob Lalezari, Ziad H. Younes, Paul J. Pockros, Adrian M. Di Bisceglie, Sanjeev Arora, G. Mani Subramanian, Yanni Zhu, Hadas Dvory-Sobol, Jenny C. Yang, Phillip S. Pang, William T. Symonds, John G. McHutchison, Andrew J. Muir, Mark Sulkowski, Paul Kwo, Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection, New England Journal of Medicine, 2014, 370, 16, 1483

    CrossRef

  5. 5
    Steve S. Choi, Lee C. Claridge, Ravi Jhaveri, Marzena Swiderska-Syn, Paul Clark, Ayako Suzuki, Thiago A. Pereira, Zhiyong Mi, Paul C. Kuo, Cynthia D. Guy, Fausto E. L. Pereira, Anna Mae Diehl, Keyur Patel, Wing-Kin Syn, Osteopontin is up-regulated in chronic hepatitis C and is associated with cellular permissiveness for hepatitis C virus replication, Clinical Science, 2014, 126, 12, 845

    CrossRef

  6. 6
    Mónica García-Álvarez, Daniel Pineda-Tenor, María A. Jiménez-Sousa, Amanda Fernández-Rodríguez, María Guzmán-Fulgencio, Salvador Resino, Relationship of vitamin D status with advanced liver fibrosis and response to hepatitis C virus therapy: A meta-analysis, Hepatology, 2014, 60, 5
  7. 7
    María Guzmán-Fulgencio, Mónica García-Álvarez, Juan Berenguer, Mª Ángeles Jiménez-Sousa, Jaime Cosín, Daniel Pineda-Tenor, Ana Carrero, Teresa Aldámiz, Emilio Álvarez, Juan Carlos López, Salvador Resino, Vitamin D deficiency is associated with severity of liver disease in HIV/HCV coinfected patients, Journal of Infection, 2014, 68, 2, 176

    CrossRef

  8. 8
    Nasser Ebrahimi Daryani, Seyed Moayed Alavian, Mohammad Hossein Somi, Mohammad Torabi-Nami, Hepatitis C and Why the Treatment is Needed Now? The Summary Report From the Cross-Border Symposium of the 5th Tehran Hepatitis Congress May 2013, Hepatitis Monthly, 2013, 13, 11

    CrossRef